MedCity News
MARCH 25, 2025
Apellis Pharmaceuticals and Astellas Pharma have the first two FDA-approved therapies for geographic atrophy, but Character Biosciences claims its approach could be best in class for treating this advanced form of dry age-related macular degeneration. The biotech’s Series B round will finance clinical tests of two programs, each addressing a different stage of the disease.
PharmaVoice
MARCH 25, 2025
As it returns from the brink, the vaccine developer has brought in Dr. Ruxandra Draghia-Akli — and her industry and public health chops — to lead R&D.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
MARCH 25, 2025
Navina closed a $55 million Series C funding round led by Goldman Sachs. The company, based in Israel and New York, uses AI to help primary care physicians thrive in value-based care models. The post Navina Snags $55M for Its Value-Based Care AI Copilot appeared first on MedCity News.
Healthcare Success
MARCH 25, 2025
Forward by Stewart Gandolf, Chief Executive Officer At Healthcare Success, we understand that a patients journey often beings with a search query. In this blog, our Technical Program Manager, Victoria Shepherd, explores the critical role of symptom search optimization. She shares how organizations can leverage this healthcare marketing trend to engage potential patients early and offers key strategies for optimizing symptom-based searches to drive patient conversions.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
MedCity News
MARCH 25, 2025
Following evidence showing that bacterial vaginosis affects both men and women, Wisp has launched a male BV partner treatment. The post Wisp Unveils Male Bacterial Vaginosis Partner Treatment appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
MARCH 25, 2025
[Sponsored] If you get migraines, you know how important it is to get quick relief. What is the best non-prescription migraine treatment? The post The Best Non-Prescription Migraine Treatment: 5 Tech Devices for Pain Relief appeared first on MedCity News.
European Pharmaceutical Review
MARCH 25, 2025
MSD (Merck) has gained global rights to develop, manufacture and commercialise an oral small molecule Lipoprotein(a) inhibitor, currently being investigated in a Phase II clinical trial for atherosclerosis.Jiangsu Hengrui Pharmaceuticals Co., Ltd (Hengrui Pharma) has agreed to license its drug candidate HRS-5346 worldwide, excluding the Greater China region.As part of the agreement, MSD will give Hengrui Pharma an initial sum of $200 million in exchange for rights to its Lp(a) inhibitor.
MedCity News
MARCH 25, 2025
[Sponsored] Contribute to the 2025 Benefit Consultant Sentiment Index! The post Help Shape the Future of Healthcare Benefits Strategy appeared first on MedCity News.
Pharma Marketing Network
MARCH 25, 2025
Healthcare professionals (HCPs) are the cornerstone of pharmaceutical success, yet reaching them has never been more complex. Between digital saturation, regulatory scrutiny, and shifting engagement preferences, marketers must be both strategic and adaptable. Understanding how to effectively engage HCPs in pharma marketing is essential for driving brand awareness, product education, and ultimately, prescription behavior.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
PharmaVoice
MARCH 25, 2025
The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development project spearheaded by MIT.
PM360
MARCH 25, 2025
LONDON, 25 March 2025 – The Creative Floor Healthcare Awards have awarded this years Talent & Diversity to four charities – Key4Life, The Ideas Foundation, School of Communication of Arts and Brixton Finishing School. The awards continue to be the only health and wellness award show in the world to donate a percentage of profits towards a Talent & Diversity Fund, that helps people from under-represented communities into health and wellness communication agencies.
pharmaphorum
MARCH 25, 2025
Sanofi's oral BTK inhibitor tolebrutinib is heading towards an FDA decision in September as a potential treatment for multiple sclerosis
Copyright Clearance Center
MARCH 25, 2025
Artificial intelligence is upending publishing, and industry leaders know theres no end in sight. Thats why they plan to win key copyright lawsuitsthen forge a path forward through Silicon Valley.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
pharmaphorum
MARCH 25, 2025
GSK joins with two UK research organisations to explore a possible link between its shingles vaccine Shingrix and a reduced risk of dementia.
Pharmaceutical Technology
MARCH 25, 2025
The study will analyse electronic health records of 65- and 66-year olds from the UKs National Health Service (NHS).
pharmaphorum
MARCH 25, 2025
A multibillion-dollar partnership between AbbVie and Genmab risks being soured by a lawsuit claiming misappropriation of trade secrets
Pharmaceutical Commerce
MARCH 25, 2025
What drivers impact the differences in expenditures?
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Pharmaceutical Technology
MARCH 25, 2025
WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on 18 March 2025.
Pharmaceutical Commerce
MARCH 25, 2025
The latest news for pharma industry insiders.
pharmaphorum
MARCH 25, 2025
MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp(a) inhibitor from China's Jiangsu Hengrui Pharma for $200m upfront
PharmaTech
MARCH 25, 2025
Under the agreement, AstraZeneca will use Alteogens proprietary hyaluronidase platform technology to develop and commercialize subcutaneous formulations of multiple oncology assets in its portfolio.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
PharmExec
MARCH 25, 2025
Under terms of the license agreement, Novo Nordisk will acquire the rights to develop and commercialize UBT251 outside of China for obesity and type 2 diabetes for an upfront payment of $200 million.
PharmaTech
MARCH 25, 2025
The contract will support R&D of high-quality APIs for substance use disorders and mental health conditions, starting with synthesis and scale-up of psilocybin, which is derived from mushrooms.
PharmExec
MARCH 25, 2025
Under terms of the deal, Merck will gain global rights to develop, manufacture, and commercialize HRS-5346 for cardiovascular disease, excluding Greater China.
PharmaTech
MARCH 25, 2025
The growing development of new biotherapeutic modalities will rely heavily on automation and progressive technologies.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmaceutical Technology
MARCH 25, 2025
Novo Nordisk has acquired the global rights to United Laboratories triple-agonist weight-loss and diabetes drug in a deal worth up to $2bn.
PharmExec
MARCH 25, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
MARCH 25, 2025
Evolving regulations in sterile manufacturing requires innovation, market knowledge, and investment. How can drug manufacturers respond?
Expert insights. Personalized for you.
175 
Let's personalize your content